Sign In

Scott Habig

SLE Global Head at UCB

Scott Habig is currently the Chief Commercial Officer (CCO) at Aurinia Pharmaceuticals Inc., a position he has held since July 2022.13 Prior to this role, he served as the SLE Global Head at UCB from February 2020 to August 2022.3

With over 20 years of experience in global and U.S. sales and marketing, Habig has extensive expertise in the rheumatology and lupus markets.2 His career highlights include:

  1. At UCB, he was responsible for pre-launch and commercial launch activities of a novel CD40 ligand in Phase III clinical development for Systemic Lupus Erythematosus (SLE).12

  2. As VP of Sales at Human Genome Sciences, he led the development of organizational capabilities for the company's first sales team and guided the launch of the first major lupus drug in over 50 years.12

  3. During his 9-year tenure at Centocor, Inc., Habig led sales and marketing strategies for one of the first biologic therapies approved for multiple autoimmune disorders, transforming a multimillion-dollar pipeline into a multibillion-dollar product.12

Habig holds a Bachelor of Arts in Mass Media Communications from The University of Akron.3

Highlights

Scott Habig - About Us :: Aurinia Pharmaceuticals Inc. (AUPH)
Jul 16 · biocentury.com
Aurinia hires EVP of R&D, commercial head and VP of IR - BioCentury
Jul 14 · businesswire.com
Aurinia Announces the Addition of Three Seasoned Executive ...

Related Questions

What are Scott Habig's key achievements at UCB?
How did Scott Habig contribute to the launch of LUPKYNIS?
What is Scott Habig's background before joining UCB?
What are Scott Habig's main responsibilities as Chief Commercial Officer at Aurinia?
How has Scott Habig's leadership style impacted his teams at UCB and Aurinia?
Scott Habig
Add to my network

Location

Atlanta Metropolitan Area